These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 401992)

  • 1. [Role of noninvasive methods in the clinical assessment of drug action in coronary disease].
    Chlebus H
    Pol Tyg Lek; 1977 Jan; 32(5):202-6. PubMed ID: 401992
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of non-invasive methods in clinical evaluation of drugs in ischaemic heart disease.
    Chlebus H
    Bibl Cardiol; 1976; (35):167-71. PubMed ID: 825097
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacodynamics of trinitrolong and sustac studied with the exercise test].
    Gritsiuk AI; Netiazhenko VZ; Amosova EN; Petrus' VG; Mil'kov MA
    Ter Arkh; 1981; 53(1):49-53. PubMed ID: 6784262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
    Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of nifedipine on the effort tolerance test in angina pectoris. Comparison with placebo and trinitroglycerine.
    Cherchi A; Fonzo R; Bina M
    G Ital Cardiol; 1974; 4(5):565-74. PubMed ID: 4215687
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency].
    Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
    Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
    Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographically evaluated circulatory response to nitroglycerin.
    Novotný J; Pavlovic J; Palecková J; Fiserová J
    Acta Univ Carol Med (Praha); 1981; 27(5-6):391-5. PubMed ID: 6817626
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-angina and coronary dilating effect of low-dose nitroglycerin].
    Sievert H; Kober G; Schneider W; Kaltenbach M; Bussmann WD
    Z Kardiol; 1989; 78 Suppl 2():48-51; discussion 64-7. PubMed ID: 2511693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cycloergometric evaluation of propatylnitrate in chronic coronary insufficiency].
    Armaganijan D; Batlouni M; Ghorayeb N; Dioguardi GS; Ogawa C
    Arq Bras Cardiol; 1980 Jan; 34(1):73-7. PubMed ID: 6996650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical assessment of practolol in coronary heart disease.
    Sznajderman M; Wasowska-Ciszek T; Jarecki M; Januszewicz W
    Acta Med Pol; 1973; 14(1):27-33. PubMed ID: 4144420
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of practolol on circulatory response after sympathetic stimulation and on plasma growth hormone and insulin levels.
    Syvälahti E; Iisalo E; Leppänen O
    Ann Clin Res; 1974 Oct; 6(5):258-65. PubMed ID: 4217121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Echocardiography during exercise and coronary disease].
    Fedele F; Agati L; Penco M; Arata L; Pastore LR; Giannico S
    Boll Soc Ital Cardiol; 1979; 24(8):817-32. PubMed ID: 551806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of nitroglycerin on cardiac performance in healthy persons and patients with coronary heart disease].
    Kozák P
    Cas Lek Cesk; 1972 Jun; 111(25):588-91. PubMed ID: 4624726
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Coronary-dilating effect of minimal doses of nitroglycerin].
    Sievert H; Bussmann WD; Selzer G; Kober G; Kaltenbach M
    Z Kardiol; 1987 Oct; 76(10):626-9. PubMed ID: 3120436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Predicting the effectiveness of nitrosorbide with regard to increasing tolerance to physical loads].
    Sledzevskaia IK; Il'iash MG
    Ter Arkh; 1986; 58(5):85-7. PubMed ID: 3526616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of human phase III. Study of Nitromint spray.
    Szegö J
    Ther Hung; 1989; 37(3):165-7. PubMed ID: 2511645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.